These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9752888)

  • 1. Paradoxical hypertension after reversal of heart failure in patients treated with intensive vasodilator therapy.
    Levine TB; Levine AB; Kathawala M; Narins B; Kaminski P
    Am J Hypertens; 1998 Sep; 11(9):1041-7. PubMed ID: 9752888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mild systolic dysfunction in heart failure (left ventricular ejection fraction >35%): baseline characteristics, prognosis and response to therapy in the Vasodilator in Heart Failure Trials (V-HeFT).
    Carson P; Johnson G; Fletcher R; Cohn J
    J Am Coll Cardiol; 1996 Mar; 27(3):642-9. PubMed ID: 8606276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse remodeling in heart failure with intensification of vasodilator therapy.
    Levine TB; Levine AB; Keteyian SJ; Narins B; Lesch M
    Clin Cardiol; 1997 Aug; 20(8):697-702. PubMed ID: 9259162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of fixed-dose isosorbide dinitrate/hydralazine on diastolic function and exercise capacity in hypertension-induced diastolic heart failure.
    Wilson RM; De Silva DS; Sato K; Izumiya Y; Sam F
    Hypertension; 2009 Sep; 54(3):583-90. PubMed ID: 19620510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of heart failure remodeling in women.
    Levine TB; Levine AB; Kaminski P; Stomel RJ
    J Womens Health Gend Based Med; 2000 Jun; 9(5):513-9. PubMed ID: 10883943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isosorbide Dinitrate, With or Without Hydralazine, Does Not Reduce Wave Reflections, Left Ventricular Hypertrophy, or Myocardial Fibrosis in Patients With Heart Failure With Preserved Ejection Fraction.
    Zamani P; Akers S; Soto-Calderon H; Beraun M; Koppula MR; Varakantam S; Rawat D; Shiva-Kumar P; Haines PG; Chittams J; Townsend RR; Witschey WR; Segers P; Chirinos JA
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28219917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Heart failure with preserved left ventricular function: clinical, echocardiographic, and clinical course features. Prognostic factors].
    Bounhoure JP; Massabuau P; Galinier M; Jordan C; Laurent JP; Marco J
    Bull Acad Natl Med; 2002; 186(6):1003-13; discussion 1013-4. PubMed ID: 12587339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary Vascular Distensibility Predicts Pulmonary Hypertension Severity, Exercise Capacity, and Survival in Heart Failure.
    Malhotra R; Dhakal BP; Eisman AS; Pappagianopoulos PP; Dress A; Weiner RB; Baggish AL; Semigran MJ; Lewis GD
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27301469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
    Cohn JN; Archibald DG; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Francis GS; Flohr KH
    N Engl J Med; 1986 Jun; 314(24):1547-52. PubMed ID: 3520315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congestive heart failure: what should be the initial therapy and why?
    Chatterjee K
    Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathogenesis of acute pulmonary edema associated with hypertension.
    Gandhi SK; Powers JC; Nomeir AM; Fowle K; Kitzman DW; Rankin KM; Little WC
    N Engl J Med; 2001 Jan; 344(1):17-22. PubMed ID: 11136955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regression of hypertensive heart hypertrophy caused by chronic angiotensin-converting enzyme inhibition].
    Motz W; Strauer BE
    Z Kardiol; 1988 Jan; 77(1):53-60. PubMed ID: 2834885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term vasodilator therapy in patients with severe aortic regurgitation.
    Evangelista A; Tornos P; Sambola A; Permanyer-Miralda G; Soler-Soler J
    N Engl J Med; 2005 Sep; 353(13):1342-9. PubMed ID: 16192479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular diastolic dyssynchrony in patients with treatment-naive hypertension and the effects of antihypertensive therapy.
    Kwon BJ; Lee SH; Park CS; Kim DB; Park HJ; Jang SW; Ihm SH; Youn HJ; Seung KB; Kim HY
    J Hypertens; 2015 Feb; 33(2):354-65. PubMed ID: 25333681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of echocardiography left ventricular filling pressures in hypertensive patients with heart failure and preserved systolic function in a North Africa unit day].
    Ali-Tatar Chentir N; Tir Y; Ouabdesselam L; Chentir MT
    Ann Cardiol Angeiol (Paris); 2016 Jun; 65(3):197-202. PubMed ID: 27180566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure.
    Mottram PM; Haluska B; Leano R; Cowley D; Stowasser M; Marwick TH
    Circulation; 2004 Aug; 110(5):558-65. PubMed ID: 15277317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension.
    Georgescu A; Popov D; Dragan E; Dragomir E; Badila E
    Eur J Pharmacol; 2007 Sep; 570(1-3):149-58. PubMed ID: 17612521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sildenafil on ventricular and vascular function in heart failure with preserved ejection fraction.
    Borlaug BA; Lewis GD; McNulty SE; Semigran MJ; LeWinter M; Chen H; Lin G; Deswal A; Margulies KB; Redfield MM
    Circ Heart Fail; 2015 May; 8(3):533-41. PubMed ID: 25782985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term prescription of beta-blocker delays the progression of heart failure with preserved ejection fraction in patients with hypertension: A retrospective observational cohort study.
    Gu J; Fan YQ; Bian L; Zhang HL; Xu ZJ; Zhang Y; Chen QZ; Yin ZF; Xie YS; Wang CQ
    Eur J Prev Cardiol; 2016 Sep; 23(13):1421-8. PubMed ID: 26915580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group.
    Francis GS; Cohn JN; Johnson G; Rector TS; Goldman S; Simon A
    Circulation; 1993 Jun; 87(6 Suppl):VI40-8. PubMed ID: 8500238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.